| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 78.45B | 69.08B | 56.86B | 61.95B | 71.62B | 60.74B |
| Gross Profit | 11.89B | 11.10B | 9.80B | 10.50B | 12.05B | 9.77B |
| EBITDA | 3.85B | 3.67B | 3.56B | 4.14B | 4.35B | 3.10B |
| Net Income | 1.48B | 1.38B | 1.01B | 1.61B | 2.03B | 1.21B |
Balance Sheet | ||||||
| Total Assets | 52.63B | 44.22B | 38.75B | 38.92B | 44.51B | 37.99B |
| Cash, Cash Equivalents and Short-Term Investments | 5.33B | 4.82B | 3.57B | 4.32B | 4.06B | 3.08B |
| Total Debt | 5.38B | 5.73B | 3.96B | 4.36B | 3.83B | 5.35B |
| Total Liabilities | 44.66B | 37.46B | 32.67B | 32.87B | 39.12B | 34.38B |
| Stockholders Equity | 7.07B | 6.07B | 5.58B | 5.59B | 4.44B | 3.56B |
Cash Flow | ||||||
| Free Cash Flow | 658.80M | -51.33M | 725.09M | 1.22B | 2.79B | 2.81B |
| Operating Cash Flow | 1.54B | 1.10B | 2.01B | 2.80B | 4.08B | 3.65B |
| Investing Cash Flow | -1.15B | -1.06B | -1.28B | -1.92B | -1.50B | -975.90M |
| Financing Cash Flow | 1.10B | 1.19B | -1.34B | -413.78M | -1.76B | -3.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$116.60B | 6.70 | 26.43% | 4.17% | 19.18% | 36.38% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | HK$959.69M | -3.07 | -2.86% | 2.94% | 2.22% | -434.25% | |
55 Neutral | HK$2.06B | -3.35 | -11.23% | ― | -11.28% | -122.85% | |
48 Neutral | HK$4.17B | 35.82 | -1.59% | ― | 32.83% | 90.24% | |
39 Underperform | HK$315.59M | 392.24 | -39.83% | ― | -52.55% | -262.35% |